Mary Engel
Fred Hutch
Seattle, WA, United States
Contact Mary
Discover and connect with journalists and influencers around the world, save time on email research, monitor the news, and more.
| Recent: |
|
| Past: |
|
Past articles by Mary:
New antibody and unique binding site offer possible paths to malaria prevention
Fred Hutch structural biologist Dr. Marie Pancera is seeking clues for designing a malaria vaccine by studying the differences between newly discovered antibodies that bind the same site on the malaria parasite. → Read More
For cancer patients with HIV, immunotherapy appears safe
Checkpoint inhibitor study suggests new treatment options for patients long excluded from cancer immunotherapy clinical trials. → Read More
Dr. Carl June weaves together HIV and cancer research to advance cures for both
Being in two camps — HIV and cancer research — at one time "made a huge, huge impact on me," says immunotherapy researcher Dr. Carl June. "With multidisciplinary interactions, it's easier to find new steps that haven't been thought about rather than incremental steps." → Read More
Community-building leads to record enrollment in HIV prevention study
Vic Sorrell knows that the secret behind a successful HIV prevention study is spending the time to establish relationships and earn trust. A pioneer in community engagement, Sorrell works for the Vanderbilt HIV Vaccine Program, a unit of the Fred Hutch-based HIV Vaccine Trials Network. → Read More
6 things to know about glioblastoma
Our experts at Fred Hutchinson Cancer Research Center offer the long view on glioblastoma diagnosis, treatment and research in light of Sen. John McCain's recent diagnosis. → Read More
Good News: CBS 'Sunday Morning' to feature Dr. Jim Olson's Tumor Paint research this weekend
Sandy Ormbrek 24th recipient of T. Evans Wyckoff Award The telephone call from Marrakesh, Morocco, was garbled and full of static, and it sounded like it was coming out of a tunnel. Nevertheless, Sandy Ormbrek could tell it was her boss, Dr. Charles Kooperberg, on the other end of the line. It took some time to understand exactly what he was saying, but the news was as unexpected as it was… → Read More
Why volunteer for an HIV cure study?
People who volunteer for HIV cure studies “want to feel like they’re contributing to the greater body of knowledge,” according to a community-led study. “But they want to feel like they can trust [the researchers], like they’re being treated with respect.” → Read More
Training tomorrow's HIV researchers
Dr. Nishila Moodley receives an award from her mentor, internationally acclaimed HIV researcher Dr. Glenda Gray, as the first graduate of the South African HVTN AIDS Vaccine Early Stage Investigator Programme. → Read More
Remembering leukemia researcher Dr. Steve Collins
Dr. Steven J. Collins' research into the molecular genetics of myeloid leukemias changed the way scientists thought about cancer cells and led to the development of one of the earliest targeted therapies. → Read More
Remembering leukemia researcher Dr. Steve Collins
Dr. Steven J. Collins' research into the molecular genetics of myeloid leukemias changed the way scientists thought about cancer cells and led to the development of one of the earliest targeted therapies. → Read More
Antimicrobial stewardship preserves a ‘shared resource’ against drug resistance
Antibiotics and other antimicrobials are unique among medications, a “shared resource” that we need to preserve, much as we steward our environment and natural resources, says Fred Hutch clinician-infectious disease researcher Dr. Catherine Liu. Overuse or misuse can lead to drug-resistant bugs that can then spread to new hosts and in some cases even spread their resistance genes to different… → Read More
Making the mentoring relationship work
Mentoring has almost a mystical status in biomedical research. But the relationship can also be so idealized that it all but invites dashed expectations. Postdoctoral fellow Dr. Athea Vichas and her mentor, developmental biologist Dr. Cecilia Moens, talk about what makes a mentoring relationship work. → Read More
A big-picture look at the world’s worst Ebola epidemic
An international team of scientists analyzed 1,610 Ebola virus genomes for the most comprehensive look to date at the how the 2013-2016 epidemic spread, proliferated and declined across the three West African countries most affected. → Read More
American Indians and Alaska Natives Tackle HIV Stigma, Talk Cure
Esther Lucero spoke at defeatHIV to raise awareness of Native Americans and Alaska Natives struggling with HIV/AIDS and to end the HIV stigma. → Read More
With Fred Hutch's HIV lab in South Africa, 'We've become full partners.'
Fred Hutch immunologist Dr. Erica Andersen-Nissen moved to Cape Town, South Africa, in 2013 to set up a state-of-the-art HIV laboratory to anchor two groundbreaking vaccine clinical trials. This is the story of building that lab, from the people up. → Read More
Community is key for new, large HIV vaccine trial
Dr. Linda-Gail Bekker, deputy director of the Desmond Tutu HIV Centre at the University of Cape Town and a member of the Fred Hutch-based HIV Vaccine Trials Network, works closely with the communities most affected by HIV to end the epidemic. She is co-chairing a just-launched clinical trial in South Africa that could lead to the first licensed HIV vaccine. → Read More
Landmark HIV Vaccine Clinical Trials Take Center Stage at World's Largest Health Conference
A landmark study is underway to test an antibody that could potentially protect people from infection by almost all strains of HIV and it's not the only one. → Read More
HIV vaccine clinical trials take center stage at world's largest global health conference
"The HIV vaccine field is open for business," said Fred Hutch's Dr. Larry Corey at International AIDS Society's biennial meeting in Durban, South Africa. → Read More
Super survivors: What those with HIV who don't get sick can teach us
Rod Fichter’s story of surviving while his partner died of AIDS was the emotional centerpiece of the HBO VICE Special Report, "Countdown to Zero." Multiply his story by 100 and you will begin to understand the exceptional volunteers who are part of a long-running Fred Hutch study on people with HIV who control the virus without medication. → Read More
Another health disparity: clinical trials
Cancer patients who live on less than $50,000 a year take part in clinical trials at a rate one-third lower than those who make more annually, according to a study published Thursday in JAMA Oncology. → Read More